摘要:
La présente invention concerne l'utilisation du trimethoxybenzyl acetylsinapate, avantageusement en combinaison avec au moins un filtre solaire, pour la protection de la peau.
摘要:
The present invention relates to compositions, methods and kits for the treatment of dermopathies. In particular, the compositions, methods and kits are particularly useful, but not limited to, the treatment of ichthyoses such as Harlequin Ichthyosis. The present invention provides a method of treating a skin condition associated with lipid dysfunction, the method comprising administering to a subject in need thereof aminosalicyclic acid (ASA), ASA derivative, or pharmaceutically acceptable salt, ester, amide, polymorph and/or prodrug thereof, thereby treating a skin condition associated with lipid dysfunction. Preferably, the skin condition associated with lipid dysfunction is an ichthyoses, for example Harlequin Ichthyosis. Preferably, the ASA is mesalamine.
摘要:
The present invention relates to the use of the root of the plant Hedychium coronarium J. Koenig and extracts derived therefrom in cosmetic applications for the treatment of skin affected by harmful environmental influences such as pollutants and UV radiation. The invention further relates to cosmetic compositions comprising Hedychium coronarium J. Koenig root extract and a process for preparing Hedychium coronarium J. Koenig root extract.
摘要:
The present invention includes compounds, compositions comprising the same, and methods using the compounds and/or compositions therein, for modulating skin pigmentation in a mammalian subject. In certain embodiments, the compounds of the invention treat or prevent skin disorders or diseases associated with hyperpigmentation in the subject. In other embodiments, the compounds of the invention act as antagonist to the non-canonical sex steroid hormone receptor GPRE1 and do not bind to a canonical nuclear estrogen receptor (ER). In yet other embodiments, the compounds of the invention comprise acts as agonists to the non-canonical sex steroid hormone receptor PAQR7 and do not bind to a canonical nuclear progesterone receptor (PR).
摘要:
Provided are: a MG-stabilized composition which comprises mycosporine-glycine (MG) and is acidic to weakly alkaline; an MG-stabilized composition which comprises MG and at most 10 parts by weight of 4-DG; and an MAA-stabilized composition which comprises MAA and at least one selected from a base constituting a nucleic acid, a nucleoside, a glycine, and a tranexamic acid.
摘要:
The aim of the present study was to investigate the effect of a combination of triiodothyroacetic acid (TRIAC) and dehydroepiandrosterone (DHEA) compared with TRIAC, DHEA or placebo alone on corticosteroid induced effect on collagen synthesis in humans. Six healthy male human volunteers aged 40-65 participated. Four areas of abdominal skin were pre-treated for 3 weeks with betamethasone valerate cream. The same areas were then treated with one of the following alternatives in the same cream vehicle: TRIAC, DHEA, TRIAC+DHEA and placebo for 2 weeks. Then suction blisters were raised in each of these areas with a vacuum pump. The blister fluid from each area was collected and frozen until analysis. Analysis of amino terminal propeptide of human type I procollagen (PINP) in suction blister fluid was performed using a commercially available immunoassay (Orion Diagnostics) kit. This study has for the first time shown that a combination of TRIAC and DHEA could effectively stimulate collagen synthesis in skin pretreated with betamethasone valerate demonstrated by an increase in PINP, and that the combination was more effective than TRIAC or DHEA alone. This combination could be used to effectively treat skin atrophy in corticosteroid induced skin atrophy. It could also be used to treat skin atrophy due to other circumstances such as e. g. sun damaged skin and skin atrophy due to high age. Another interesting application would be to combine TRIAC and DHEA with a potent corticosteroid in order to prevent corticosteroid induced skin atrophy. If this combination still is effective in the treatment of eczema and psoriasis and without the risk of skin atrophy this combination will be a major breakthrough for the use of potent topical corticosteroids.